Bankrupt

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Lars Windhorst’s Tennor Holding, which borrowed billions from investors and …

23andMe’s former CEO is set to regain control of the genetic testing company after a $305m bid from a non-profit she controls topped a pharmaceutical company’s offer for it in …

The drugmaker Regeneron Pharmaceuticals has agreed to buy the genetic testing firm 23andMe Holding for $256m through a bankruptcy auction, the companies announced on Monday. Regeneron said it will comply …